Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details
In Brief: Lobuglio Named Alabama Comprehensive Center Director; NCI FY 1983 Funds Will Be $983.6 Million
Fred Conrad, MDA VP, Shot To Death In Hospital Office
CCOP Reviewers Briefed On Program Objective, Criteria
Cell Culture ID Offered By NIC
Drug Discovery Group Announcement Issued
Tumor Classification, Monoclonal Antibody Announcements Made
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy
- Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure - Alec Kimmelman announced as next CEO and Dean of NYU Langone Health
